PyInvesting

Market research

PFE.F Pfizer Inc

F EUR Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
137B
P/E ratio
36.99
Analyst target
Not available
Dividend yield
7.1%
Beta
0.28

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

Pfizer Inc is currently in a long term uptrend where the price is trading 6.5% above its 200 day moving average.

From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.9.

Pfizer Inc's total revenue sank by 7.9% to $12B since the same quarter in the previous year.

Its net income has increased by 276.8% to $594M since the same quarter in the previous year.

Finally, its free cash flow grew by 42.6% to $4B since the same quarter in the previous year.

Based on the above factors, Pfizer Inc gets an overall score of 4/5.